Body composition parameters were associated with response to abiraterone acetate and prognosis in patients with metastatic castration‐resistant prostate cancer

OBJECTIVE: To investigate the predictive value of body composition parameters for biochemical response to abiraterone acetate (AA) in metastatic castration‐resistant prostate cancer (mCRPC) patients with prior chemohormonal therapy. METHODS: We retrospectively evaluated the clinicopathologic informa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ke, Zhi‐Bin, You, Qi, Xue, Yu‐Ting, Sun, Jiang‐Bo, Chen, Jia‐Yin, Liu, Wen‐Qi, Wei, Yong, Zheng, Qing‐Shui, Li, Xiao‐Dong, Xue, Xue‐Yi, Xu, Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134370/
https://www.ncbi.nlm.nih.gov/pubmed/36750989
http://dx.doi.org/10.1002/cam4.5640

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134370/
https://www.ncbi.nlm.nih.gov/pubmed/36750989
http://dx.doi.org/10.1002/cam4.5640

Ejemplares similares